SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are experiencing significant volatility following a JPMorgan sell rating and a broader rotation out of biotech, despite ongoing community excitement regarding the company's expanding oncology pipeline and upcoming regulatory milestones for its flu vaccine. Investors are actively debating the company's long-term commercial potential versus concerns over cash burn and potential policy shifts impacting the vaccine landscape.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense social media activity as users debate the stock's sentiment-driven nature and the political controversy surrounding Donald Trump's ongoing policy decisions. The community is sharply divided, with intense arguments centered on the economic impact of his administration's tariffs, geopolitical tensions in the Middle East, and the company's polarizing influence on market dynamics.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors weigh a double-beat earnings report and raised guidance against concerns over future margin pressures and an uneven consumer retail environment. While the community is actively debating the durability of the retailer's turnaround and its reliance on one-time tariff refunds, sentiment remains polarized between those focused on strong traffic metrics and those wary of the stock's year-to-date rally.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investor focus intensifies on the company's aggressive oncology pipeline expansion, fueled by anticipation of key clinical trial readouts and ongoing buyout speculation. Market sentiment is heavily driven by the need to navigate the looming patent expiration of Keytruda, with active community discussion centering on potential M&A targets and the commercial prospects of recent drug approvals.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors await its upcoming earnings report, with community attention focused on the company's licensing-driven pivot and potential updates on its COVID-19 and influenza combination vaccine. Discussions highlight high institutional ownership and speculation regarding a possible strategic partnership or acquisition, despite frustration over the CEO's communication style and lack of concrete deal disclosures.

TOYO Co. Ltd. engages in the design, manufacture, and sale of solar cells and modules. It is involved in integrating the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and potentially other stages of the solar power supply chain. The company was founded on November 8, 2022 and is headquartered in Tokyo, Japan.

TOYO Co Ltd.

TOYO Co., Ltd

Toyo Co. is trending due to the company's strong, profitable Q1 2026 results that showed significant year-over-year growth, contrasting sharply with the stock's current undervalued market capitalization. The community is actively discussing the disconnect between its solid fundamental performance and the stock's recent price action, with many investors pointing to substantial potential upside from U.S. manufacturing expansion and pending tax credit eligibility.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is experiencing significant market interest following a $37.50 rival buyout offer from an Israeli group, which challenges the previously agreed $35 deal with Hapag-Lloyd. The community is actively debating the implications of this competing bid on potential regulatory approvals, the prospect of an escalating bidding war, and the long-term strategic benefits of maintaining Israeli control over the company.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowe's shares are experiencing volatility as investors weigh a narrow revenue miss and cautious fiscal outlook against resilience in the Pro and home services segments. The community remains focused on whether macro pressures in discretionary DIY spending will continue to weigh on the stock, or if upcoming interest rate adjustments might help stabilize demand for home improvement projects.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently in the spotlight as investors await a crucial June 1st readout for the Moderna-partnered melanoma vaccine, a program viewed as a potential major catalyst. The community is actively discussing the company's pending merger with Tempus AI, debating whether the $16.25 per share valuation represents a fair exit or if it undervalues the company's long-term potential in the oncology diagnostics market.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is facing intense downward price pressure following a significant sell-off, prompting heavy community debate over whether this represents a long-term buying opportunity or a failed project. While some investors remain bullish on its foundational partnerships and potential for real-world asset tokenization, others are increasingly vocal about their frustration with the lack of transparency and the overall performance of the asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BB Would you risk being short BlackBerry knowing Alloy Kore revenue will be greater than 100 percent of current QNX revenue and that is the low estimate from Blackberry Management.

DasCoutts

Michael

Motts

BayStBull

Thom

Yasch22

S BRACK

$BB any update on possible release date ? 

Isn’t this Friday the 2 month timeline ?

StockTwits for iOS

Richandbroke

StockTwits For Android 

BlackBerry Ltd

 Would you risk being short BlackBerry knowing Alloy Kore revenue will be greater than 100 percent of current QNX revenue and that is the low estimate from Blackberry Management.